✦ LIBER ✦

Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patients

✍ Scribed by Vrignaud, P.; Eghbali, H.; Hoerni, B.; Iliadis, A.; Robert, J.

Book ID: 121909012
Publisher: Elsevier Science
Year: 1985
Weight: 666 KB
Volume: 21
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(85)90309-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

563 Pharmacokinetics of epirubicin and p

563 Pharmacokinetics of epirubicin and paclitaxel during weekly administration in patients with metastasised breast cancer

✍ R.M. Mader; B. Rizovski; C. Wenzel; R. Bartsch; C.C. Zielinski; G.G. Steger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Pharmacokinetics and metabolism of thior

Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants

✍ Wladyslawa A Daniel; Maciej Syrek; Anna Haduch; Jacek Wójcikowski 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB

Intrasubject variation in children of if

Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration

✍ A. V. Boddy; S. Murray Yule; Ruth Wyllie; Lisa Price; Andrew D. J. Pearson; Jeff 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 300 KB

Pharmacokinetics and metabolism of spiro

Pharmacokinetics and metabolism of spirobromine in oral administration

✍ O. V. Ol'shanskaya; V. I. Pol'shakov; Zh. F. Presnova; V. A. Chernov; T. S. Safo 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 204 KB

Pharmacokinetics of doxorubicin and epir

Pharmacokinetics of doxorubicin and epirubicin in mice during chlorpromazine-induced hypothermia

✍ L. Lundgren-Eriksson; A. Carlsson; S. Eksborg; W. Ryd; R. Vesanen; R. Hultborn 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 182 KB

Natural killer cell activity during the

Natural killer cell activity during the course of disease in patients with Hodgkin's disease

✍ Irena Frydecka 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 2 views

Natural killer (NK) activity was investigated in 61 patients with Stage I11 and IV Hodgkin's disease during the course of disease and in 30 healthy age-and sex-matched healthy volunteers. The mean NK activity was significantly lower (P < 0.001) in untreated patients and in patients in the active pha